- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/46 - Oxygen atoms
Patent holdings for IPC class C07D 213/46
Total number of patents in this class: 98
10-year publication summary
|
7
|
3
|
6
|
6
|
7
|
3
|
1
|
8
|
4
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Purdue Pharma L.P. | 501 |
6 |
| Isosterix, Inc. | 7 |
4 |
| F. Hoffmann-La Roche AG | 7947 |
3 |
| The Regents of the University of California | 19961 |
3 |
| Corteva Agriscience LLC | 2682 |
3 |
| Roche Diagnostics GmbH | 2701 |
2 |
| Roche Diagnostics Operations, Inc. | 1492 |
2 |
| Merck Patent GmbH | 5815 |
2 |
| Syngenta Participations AG | 1904 |
2 |
| BioMarin Pharmaceutical Inc. | 374 |
2 |
| Board of Trustees of Southern Illinois University | 99 |
2 |
| CHDI Foundation, Inc. | 106 |
2 |
| Northeastern University | 1193 |
2 |
| Vanderbilt University | 1907 |
2 |
| Inflazome Limited | 85 |
2 |
| Landos Biopharma, Inc. | 37 |
2 |
| Prazertherapeutics Inc. | 9 |
2 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 158 |
2 |
| Bristol-myers Squibb Company | 4880 |
1 |
| BASF SE | 20940 |
1 |
| Other owners | 51 |